ArticleWorld journal of urology2026
Bladder neck angle as an anatomical predictor of conservative treatment failure and the need for surgery in benign prostatic obstruction.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the predictive value of bladder neck angle (BNA) for trial without catheter (TWOC) following acute urinary retention (AUR) due to benign prostatic obstruction (BPO), and to evaluate its role in predicting response to conservative therapy in patients with lower urinary tract symptoms (LUTS).
methodsOutpatients presenting with bothersome LUTS or acute urinary retention (AUR) due to BPO were included in the cohort. The prostate volume, intravesical prostatic protrusion, BNA, and postvoid residual volume were recorded. In patients with AUR, TWOC was performed after 2 weeks of alpha-blocker therapy; those with LUTS received alpha-blockers and 5-alpha reductase inhibitors for 12 months. Surgery was recommended for patients who experienced failure of conservative treatment. The uroflowmetry and International Prostate Symptom Score (IPSS) changes were assessed from baseline to 12 months after treatment.
resultsAmong 66 patients with AUR, 32 (48.5%) experienced TWOC failure. BNA demonstrated strong discriminative ability for predicting TWOC failure (AUC 0.855, 95% CI 0.76-0.94), with an optimal cut-off of 89.94° (sensitivity 75%, specificity 84%), outperforming IPP (AUC 0.794, 95% CI 0.68-0.91). Among 335 non-AUR patients receiving combination therapy, 23 (6.8%) required surgery. BNA predicted treatment failure with an AUC of 0.87 and an optimal cut-off of 75.85° (sensitivity 78%, specificity 87%).
conclusionsBNA is a promising anatomical predictor of TWOC outcome in AUR and may help identify LUTS patients who are likely to experience greater benefit from conservative therapy. Incorporating BNA into clinical assessment may improve risk stratification and treatment planning in BPO management.
Indexed as
Identifiers
42371117What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.